Establishing a clinical phenotype for cachexia in end stage kidney disease – study protocol
Abstract Background Surveys using traditional measures of nutritional status indicate that muscle wasting is common among persons with end-stage kidney disease (ESKD). Up to 75% of adults undergoing maintenance dialysis show some evidence of muscle wasting. ESKD is associated with an increase in inf...
Main Authors: | Joanne Reid, Helen R. Noble, Gary Adamson, Andrew Davenport, Ken Farrington, Denis Fouque, Kamyar Kalantar-Zadeh, John Mallett, C. McKeaveney, S. Porter, David S. Seres, Joanne Shields, Adrian Slee, Miles D. Witham, Alexander P. Maxwell |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-02-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12882-018-0819-3 |
Similar Items
-
Developing an Evidence and Theory Based Multimodal Integrative Intervention for the Management of Renal Cachexia: A Theory of Change
by: Carolyn Blair, et al.
Published: (2022-11-01) -
Exploring the lived experience of renal cachexia for individuals with end-stage renal disease and the interrelated experience of their carers: Study protocol.
by: Carolyn Blair, et al.
Published: (2022-01-01) -
Kidney cachexia or protein‐energy wasting in chronic kidney disease: facts and numbers
by: Laetitia Koppe, et al.
Published: (2019-06-01) -
COVID‐19: a major cause of cachexia and sarcopenia?
by: John E. Morley, et al.
Published: (2020-08-01) -
Non‐steroidal anti‐inflammatory drugs for treatment of cancer cachexia: A systematic review
by: Megan Bowers, et al.
Published: (2023-12-01)